Cargando…
Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts
Alzheimer’s disease biomarkers are becoming increasingly important for characterizing the longitudinal course of disease, predicting the timing of clinical and cognitive symptoms, and for recruitment and treatment monitoring in clinical trials. In this work, we develop and evaluate three methods for...
Autores principales: | Betthauser, Tobey J, Bilgel, Murat, Koscik, Rebecca L, Jedynak, Bruno M, An, Yang, Kellett, Kristina A, Moghekar, Abhay, Jonaitis, Erin M, Stone, Charles K, Engelman, Corinne D, Asthana, Sanjay, Christian, Bradley T, Wong, Dean F, Albert, Marilyn, Resnick, Susan M, Johnson, Sterling C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679170/ https://www.ncbi.nlm.nih.gov/pubmed/35856240 http://dx.doi.org/10.1093/brain/awac213 |
Ejemplares similares
-
Trajectory of clinical symptoms in relation to amyloid chronicity
por: Birdsill, Alex C., et al.
Publicado: (2022) -
Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020) -
Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
por: Betthauser, Tobey J, et al.
Publicado: (2020) -
Amyloid beta associations with connected speech in cognitively unimpaired adults
por: Mueller, Kimberly D., et al.
Publicado: (2021) -
Item-Level Story Recall Predictors of Amyloid-Beta in Late Middle-Aged Adults at Increased Risk for Alzheimer’s Disease
por: Mueller, Kimberly D., et al.
Publicado: (2022)